Why the study?
Does recombinant human growth hormone improve cardiac hemodynamics and function in patients with idiopathic dilated cardiomyopathy and moderate-to-severe heart failure?
Population
7 patients with idiopathic dilated cardiomyopathy and moderate-to-severe heart failure
Design
Case_series
Follow-up
3 months of therapy and 3 months after discontinuation
Authors
Loading...
May improve hemodynamics in idiopathic dilated cardiomyopathy; hypothesis-generating and requires randomized confirmation before clinical use.
Does recombinant human growth hormone improve cardiac hemodynamics and function in patients with idiopathic dilated cardiomyopathy and moderate-to-severe heart failure?
In a small preliminary study, recombinant human growth hormone improved hemodynamics, myocardial energy metabolism, and clinical status in patients with idiopathic dilated cardiomyopathy.
Fazio et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: